Interaction between interleukin-1β -31T/C gene polymorphism and drinking and smoking habits on the risk of hepatocellular carcinoma among Japanese

Cancer Letters

Volumn 271, Issue 1, 2008, Pages 98-104

  Sakamoto, Tatsuhiko ^a   Higaki, Yasuki ^a   Hara, Megumi ^a   Ichiba, Masayoshi ^a   Horita, Mikako ^a   Mizuta, Toshihiko ^a   Eguchi, Yuichiro ^a   Yasutake, Tsutomu ^a   Ozaki, Iwata ^a   Yamamoto, Kyosuke ^a   Onohara, Shingo ^b   Kawazoe, Seiji ^b   Shigematsu, Hirohisa ^b   Koizumi, Shunzo ^a   Tanaka, Keitaro ^a  

^a SAGA UNIVERSITY   (Japan)

^b Saga Prefectural Hospital Koseikan   (Japan)

Author keywords

Alcohol; Case control study; Hepatocellular carcinoma; Interleukin 1 ; Smoking; Tumor necrosis factor

Indexed keywords

ALCOHOL; CYTOKINE; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CANCER RISK; CHRONIC LIVER DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; DRINKING BEHAVIOR; FEMALE; GENE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; IL 1B GENE; INFLAMMATION; JAPAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SMOKING; TNF A GENE; TOBACCO; GENETIC PREDISPOSITION; GENETICS; LIVER TUMOR; MIDDLE AGED; RISK FACTOR;

NICOTIANA TABACUM;

ADULT; AGED; ALCOHOL DRINKING; CARCINOMA, HEPATOCELLULAR; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-1BETA; JAPAN; LIVER NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS; SMOKING;

EID: 53049086519     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.05.036     Document Type: Article

References (32)

1. Tanaka K., Hirohata T., Koga S., Sugimachi K., Kanematsu T., Ohryohji F., Nawata H., Ishibashi H., Maeda Y., Kiyokawa H., Tokunaga K., Irita Y., Takeshita S., Arase Y., and Nishino N. Hepatitis C and hepatitis B in the etiology of hepatocellular carcinoma in the Japanese population. Cancer Res. 51 (1991) 2842-2847
2. Tsukuma H., Hiyama T., Tanaka S., Nakao M., Yabuuchi T., Kitamura T., Nakanishi K., Fujimoto I., Inoue A., Yamazaki H., and Kawashima T. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N. Engl. J. Med. 328 (1993) 1797-1801
3. Donato F., Tagger A., Gelatti U., Parrinello G., Boffetta P., Albertini A., Decarli A., Trevisi P., Ribero M.L., Martelli C., Porru S., and Nardi G. Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women. Am. J. Epidemiol. 155 (2002) 323-331
4. International Agency for Research on Cancer, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Volume 83, Tobacco Smoke and Involuntary Smoking, IARC, Lyon, France, 2004.
5. Takano S., Yokosuka O., Imazeki F., Tagawa M., and Omata M. Incidence of hepatocellular carcinoma in chronic hepatitis B and C: a prospective study of 251 patients. Hepatology 21 (1995) 650-655
6. Tarao K., Rino Y., Ohkawa S., Shimizu A., Tamai S., Miyakawa K., Aoki H., Imada T., Shindo K., Okamoto N., and Totsuka S. Association between high serum alanine aminotransferase levels and more rapid development and higher rate of incidence of hepatocellular carcinoma in patients with hepatitis C virus-associated cirrhosis. Cancer 86 (1999) 589-595
7. Coussens L.M., and Werb Z. Inflammation and cancer. Nature 420 (2002) 860-867
8. Yoshimura A. Signal transduction of inflammatory cytokines and tumor development. Cancer Sci. 97 (2006) 439-447
9. Hamajima N., Matsuo K., Saito T., Tajima K., Okuma K., Yamao K., and Tominaga S. Interleukin 1 polymorphisms, lifestyle factors, and Helicobacter pylori infection. Jpn. J. Cancer Res. 92 (2001) 383-389
10. Tanaka Y., Furuta T., Suzuki S., Orito E., Yeo A.E., Hirashima N., Sugauchi F., Ueda R., and Mizokami M. Impact of interleukin-1beta genetic polymorphisms on the development of hepatitis C virus-related hepatocellular carcinoma in Japan. J. Infect. Dis. 187 (2003) 1822-1825
11. Wang Y., Kato N., Hoshida Y., Yoshida H., Taniguchi H., Goto T., Moriyama M., Otsuka M., Shiina S., Shiratori Y., Ito Y., and Omata M. Interleukin-1beta gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection. Hepatology 37 (2003) 65-71
12. Chen C.C., Yang S.Y., Liu C.J., Lin C.L., Liaw Y.F., Lin S.M., Lee S.D., Chen P.J., Chen C.J., and Yu M.W. Association of cytokine and DNA repair gene polymorphisms with hepatitis B-related hepatocellular carcinoma. Int. J. Epidemiol. 34 (2005) 1310-1318
13. Hirankarn N., Kimkong I., Kummee P., Tangkijvanich P., and Poovorawan Y. Interleukin-1beta gene polymorphism associated with hepatocellular carcinoma in hepatitis B virus infection. World J. Gastroenterol. 12 (2006) 776-779
14. Vatay A., Bene L., Kovacs A., Prohaszka Z., Szalai C., Romics L., Fekete B., Karadi I., and Fust G. Relationship between the tumor necrosis factor alpha polymorphism and the serum C-reactive protein levels in inflammatory bowel disease. Immunogenetics 55 (2003) 247-252
15. Aoki T., Hirota T., Tamari M., Ichikawa K., Takeda K., Arinami T., Shibasaki M., and Noguchi E. An association between asthma and TNF-308G/A polymorphism: meta-analysis. J. Hum. Genet. 51 (2006) 677-685
16. Kamizono S., Hiromatsu Y., Seki N., Bednarczuk T., Matsumoto H., Kimura A., and Itoh K. A polymorphism of the 5′ flanking region of tumour necrosis factor alpha gene is associated with thyroid-associated ophthalmopathy in Japanese. Clin. Endocrinol. 52 (2000) 759-764
17. Ho S.Y., Wang Y.J., Chen H.L., Chen C.H., Chang C.J., Wang P.J., Chen H.H., and Guo H.R. Increased risk of developing hepatocellular carcinoma associated with carriage of the TNF2 allele of the -308 tumor necrosis factor-alpha promoter gene. Cancer Causes Control 15 (2004) 657-663
18. Nishimura M., Kuno S., Kaji R., and Kawakami H. Influence of a tumor necrosis factor gene polymorphism in Japanese patients with multiple system atrophy. Neurosci. Lett. 374 (2005) 218-221
19. Soga Y., Nishimura F., Ohyama H., Maeda H., Takashiba S., and Murayama Y. Tumor necrosis factor-alpha gene (TNF-alpha) -1031/-863, -857 single-nucleotide polymorphisms (SNPs) are associated with severe adult periodontitis in Japanese. J. Clin. Periodontol. 30 (2003) 524-531
20. Mandrekar P., Catalano D., White B., and Szabo G. Moderate alcohol intake in humans attenuates monocyte inflammatory responses: inhibition of nuclear regulatory factor kappa B and induction of interleukin 10. Alcohol Clin. Exp. Res. 30 (2006) 135-139
21. Tappia P.S., Troughton K.L., Langley-Evans S.C., and Grimble R.F. Cigarette smoking influences cytokine production and antioxidant defences. Clin. Sci. 88 (1995) 485-489
22. Ikai I., Arii S., Ichida T., Okita K., Omata M., Kojiro M., Takayasu K., Nakanuma Y., Makuuchi M., Matsuyama Y., and Yamaoka Y. Report of the 16th follow-up survey of primary liver cancer. Hepatol. Res. 32 (2005) 163-172
23. Sakamoto T., Hara M., Higaki Y., Ichiba M., Horita M., Mizuta T., Eguchi Y., Yasutake T., Ozaki I., Yamamoto K., Onohara S., Kawazoe S., Shigematsu H., Koizumi S., and Tanaka K. Influence of alcohol consumption and gene polymorphisms of ADH2 and ALDH2 on hepatocellular carcinoma in a Japanese population. Int. J. Cancer 118 (2006) 1501-1507
24. Hamajima N., Shibata A., Katsuda N., Matsuo K., Ito H., Saito T., Tajima K., and Tominaga S. Subjects with TNF-A-857TT and -1031TT genotypes showed the highest Helicobacter pylori seropositive rate compared with those with other genotypes. Gastric Cancer 6 (2003) 230-236
25. Hara M., Tanaka K., Sakamoto T., Higaki Y., Mizuta T., Eguchi Y., Yasutake T., Ozaki I., Yamamoto K., Onohara S., Kawazoe S., Shigematsu H., and Koizumi S. Case-control study on cigarette smoking and the risk of hepatocellular carcinoma among Japanese. Cancer Sci. 99 (2008) 93-97
26. El-Omar E.M., Carrington M., Chow W.H., McColl K.E., Bream J.H., Young H.A., Herrera J., Lissowska J., Yuan C.C., Rothman N., Lanyon G., Martin M., Fraumeni Jr. J.F., and Rabkin C.S. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404 (2000) 398-402
27. Johansson A.S., Liden J., Okret S., and Palmblad J.E. Effects of ethanol on cytokine generation and NFkappaB activity in human lung epithelial cell. Biochem. Pharmacol. 70 (2005) 545-551
28. Nagai S., Takeuchi M., Watanabe K., Aung H., and Izumi T. Smoking and interleukin-1 activity released from human alveolar macrophages in healthy subjects. Chest 94 (1988) 694-700
29. Higuchi T., Seki N., Kamizono S., Yamada A., Kimura A., Kato H., and Itoh K. Polymorphism of the 5′-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese. Tissue Antigens 51 (1998) 605-612
30. Wilson A.G., Symons J.A., McDowell T.L., McDevitt H.O., and Duff G.W. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc. Natl. Acad. Sci. USA 94 (1997) 3195-3199
31. Louis E., Franchimont D., Piron A., Gevaert Y., Schaaf-Lafontaine N., Roland S., Mahieu P., Malaise M., De Groote D., Louis R., and Belaiche J. Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin. Exp. Immunol. 113 (1998) 401-406
32. Lu C.C., Sheu B.S., Chen T.W., Yang H.B., Hung K.H., Kao A.W., Chuang C.H., and Wu J.J. Host TNF-alpha -1031 and -863 promoter single nucleotide polymorphisms determine the risk of benign ulceration after H. pylori infection. Am. J. Gastroenterol. 100 (2005) 1274-1282